These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 37459785)

  • 1. Increased serum interleukin-6 and lactate dehydrogenase levels among nonsurvival severe COVID-19 patients when compared to survival ones.
    Haroun RA; Osman WH; Amin RE; Eessa AM; Saad S
    Int Immunopharmacol; 2023 Sep; 122():110626. PubMed ID: 37459785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of diagnostic and prognostic laboratory biomarkers in severe COVID-19 patients admitted to intensive care unit.
    Fawzy M; Ahmed SS; Abdelhady SA
    Egypt J Immunol; 2023 Jan; 30(1):1-13. PubMed ID: 36588448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The predictive and prognostic role of hematologic and biochemical parameters in the emergency department among coronavirus disease 2019 patients.
    Huang CY; Tsai HW; Liu CY; Liu TH; Huang HL; Chang CC; Chen WC; Sun JT
    Chin J Physiol; 2021; 64(6):306-311. PubMed ID: 34975124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laboratory biomarker predictors for disease progression and outcome among Egyptian COVID-19 patients.
    Fathalla LA; Kamal LM; Salaheldin O; Khalil MA; Kamel MM; Fahim HH; Abdel-Moneim YA; Abdulhakim JA; Abdel-Moneim AS; El-Meligui YM
    Int J Immunopathol Pharmacol; 2022; 36():3946320221096207. PubMed ID: 35622504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poor Prognostic Biochemical Markers Predicting Fatalities Caused by COVID-19: A Retrospective Observational Study From a Developing Country.
    Asghar MS; Haider Kazmi SJ; Khan NA; Akram M; Hassan M; Rasheed U; Ahmed Khan S
    Cureus; 2020 Aug; 12(8):e9575. PubMed ID: 32913691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The diagnostic value of serum C-reactive protein, procalcitonin, interleukin-6 and lactate dehydrogenase in patients with severe acute pancreatitis.
    Tian F; Li H; Wang L; Li B; Aibibula M; Zhao H; Feng N; Lv J; Zhang G; Ma X
    Clin Chim Acta; 2020 Nov; 510():665-670. PubMed ID: 32828732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences of inflammatory and non-inflammatory indicators in Coronavirus disease-19 (COVID-19) with different severity.
    Wang M; Zhu Q; Fu J; Liu L; Xiao M; Du Y
    Infect Genet Evol; 2020 Nov; 85():104511. PubMed ID: 32858231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum biomarker panel for disease severity and prognosis in patients with COVID-19.
    Li J; Tang M; Liu D; Xie Z; Wang F; Yang Y
    J Clin Lab Anal; 2023 Jan; 37(2):e24831. PubMed ID: 36604799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory Response in COVID-19 Depending on the Severity of the Disease and the Vaccination Status.
    Trofin F; Nastase EV; Roșu MF; Bădescu AC; Buzilă ER; Miftode EG; Manciuc DC; Dorneanu OS
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality in Patients of COVID-19 Infection: Biochemical Markers and its Cut-off Values for Predicting Outcome.
    Yousaf MN; Sarwar S; Tarique S; Ahmed M; Tahir H
    J Coll Physicians Surg Pak; 2022 Jan; 32(1):37-41. PubMed ID: 34983145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Evaluation of Laboratory Parameters as Predictors of Disease Severity and Mortality in COVID-19 Patients: A Retrospective Study From a Tertiary Care Hospital in India.
    Dwivedi T; Raj A; Das N; Gupta R; Gupta N; Tiwari P; Sahoo B; Sagiraju HKR; Sirohiya P; Ratre B; Elavarasi A; Mohan A; Bhatnagar S
    Cureus; 2023 Jun; 15(6):e40273. PubMed ID: 37448393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic and early prognostic value of serum CRP and LDH levels in patients with possible COVID-19 at the first admission.
    Akdogan D; Guzel M; Tosun D; Akpinar O
    J Infect Dev Ctries; 2021 Jun; 15(6):766-772. PubMed ID: 34242184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 'Immune-inflammatory markers & clinical characteristics for outcomes in hospitalized SARS-CoV-2 infected patients of Pakistan: a retrospective analysis'.
    Khalid A; Aqeel RF; Nawaz A; Ahmad J; Fatima ST; Shahid S; Rao AA; Aktas G; Ijaz S; Shehryar M
    Hematology; 2023 Dec; 28(1):2199629. PubMed ID: 37408482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophil to lymphocytic ratio and other inflammatory markers as adverse outcome predictor in hospitalized COVID-19 patients.
    Abdelhady SA; Rageh F; Ahmed SS; Al-Touny SA; Riad E; Elhoseeny MM; Khalifa AA; Salim A; Farghly MI; Elgamal R
    Egypt J Immunol; 2022 Apr; 29(2):57-67. PubMed ID: 35436055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical features and risk factors for secondary hemophagocytic lymphohistiocytosis in elderly patients with severe SARS-CoV-2 infection: a multicenter retrospective cohort study].
    Deng Y; Lu S; Zhang G; Sun W; Chu Y; Meng M; Cui Y; Li P
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Aug; 35(8):793-799. PubMed ID: 37593855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Routine laboratory testing to determine if a patient has COVID-19.
    Stegeman I; Ochodo EA; Guleid F; Holtman GA; Yang B; Davenport C; Deeks JJ; Dinnes J; Dittrich S; Emperador D; Hooft L; Spijker R; Takwoingi Y; Van den Bruel A; Wang J; Langendam M; Verbakel JY; Leeflang MM;
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD013787. PubMed ID: 33211319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secretory Phospholipase A2 and Interleukin-6 Levels as Predictive Markers of the Severity and Outcome of Patients with COVID-19 Infections.
    Urazov S; Chernov A; Popov O; Klenkova N; Sushentseva N; Polkovnikova I; Apalko S; Kislyuk K; Pavlovich D; Ivanov A; Shcherbak S
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory and hematologic markers as predictors of severe outcomes in COVID-19 infection: A systematic review and meta-analysis.
    Hariyanto TI; Japar KV; Kwenandar F; Damay V; Siregar JI; Lugito NPH; Tjiang MM; Kurniawan A
    Am J Emerg Med; 2021 Mar; 41():110-119. PubMed ID: 33418211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of inflammatory biomarkers in patients with COVID-19 infections: Bahrain experience.
    Farid E; Sridharan K; Alsegai OA; Khawaja SA; Mansoor EJ; Teraifi NA; Qahtani MA; Salman JA
    Biomark Med; 2021 Jun; 15(8):541-549. PubMed ID: 33988463
    [No Abstract]   [Full Text] [Related]  

  • 20. IL-6-based mortality risk model for hospitalized patients with COVID-19.
    Laguna-Goya R; Utrero-Rico A; Talayero P; Lasa-Lazaro M; Ramirez-Fernandez A; Naranjo L; Segura-Tudela A; Cabrera-Marante O; Rodriguez de Frias E; Garcia-Garcia R; Fernández-Ruiz M; Aguado JM; Martinez-Lopez J; Lopez EA; Catalan M; Serrano A; Paz-Artal E
    J Allergy Clin Immunol; 2020 Oct; 146(4):799-807.e9. PubMed ID: 32710975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.